HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher C Moore Selected Research

Sepsis (Septicemia)

1/2023Decision Analytic Modeling for Global Clinical Trial Planning: A Case for HIV-Positive Patients at High Risk for Mycobacterium tuberculosis Sepsis in Uganda.
1/2022Early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa: a protocol of a randomised clinical trial.
6/2021Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical Illness.
12/2019Imputation of partial pressures of arterial oxygen using oximetry and its impact on sepsis diagnosis.
4/2019Effect of Empiric Anti-Mycobacterium tuberculosis Therapy on Survival Among Human Immunodeficiency Virus-Infected Adults Admitted With Sepsis to a Regional Referral Hospital in Uganda.
1/2016Outcomes of patients with severe sepsis after the first 6 hours of resuscitation at a regional referral hospital in Uganda.
1/2014Toll-like receptor 4 stimulation before or after Streptococcus pneumoniae induced sepsis improves survival and is dependent on T-cells.
5/2013Malaria is an uncommon cause of adult sepsis in south-western Uganda.
7/2012The impact of early monitored management on survival in hospitalized adult Ugandan patients with severe sepsis: a prospective intervention study*.
11/2009Severe sepsis in two Ugandan hospitals: a prospective observational study of management and outcomes in a predominantly HIV-1 infected population.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christopher C Moore Research Topics

Disease

14Sepsis (Septicemia)
01/2023 - 01/2008
9Infections
11/2023 - 08/2013
7Malaria
11/2023 - 05/2009
3Neoplasms (Cancer)
05/2024 - 07/2021
3Hypoxia (Hypoxemia)
01/2023 - 12/2019
3Inflammation (Inflammations)
08/2013 - 10/2008
2Tuberculosis (Tuberculoses)
11/2023 - 01/2023
2Fever (Fevers)
11/2023 - 07/2021
2Communicable Diseases (Infectious Diseases)
12/2021 - 10/2017
2Shock
10/2017 - 10/2008
2Coma (Comas)
01/2016 - 05/2013
2Blastomycosis
12/2015 - 06/2014
2Bacterial Meningitis
01/2013 - 01/2012
1Leukemia
07/2021
1Meningitis
06/2021
1Critical Illness (Critically Ill)
06/2021
1Neutropenia
12/2020
1Hypertension (High Blood Pressure)
01/2019
1Septic Shock (Toxic Shock Syndrome)
10/2017
1Pulmonary Tuberculosis
01/2015
1Confusion (Bewilderment)
05/2013
1Viral Meningitis
01/2012
1Hypoglycemia (Reactive Hypoglycemia)
10/2011
1Acute Lung Injury
11/2008

Drug/Important Bio-Agent (IBA)

6Anti-Bacterial Agents (Antibiotics)IBA
11/2023 - 11/2009
4Lactic Acid (Lactate)FDA LinkGeneric
01/2016 - 01/2008
3Oxygen (Dioxygen)IBA
01/2023 - 12/2019
2lipoarabinomannan (LAM)IBA
11/2023 - 01/2023
2Antimalarials (Antimalarial Agents)IBA
02/2021 - 01/2017
2CytokinesIBA
08/2013 - 11/2008
2LipopolysaccharidesIBA
11/2008 - 10/2008
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2024
1Vitamin EFDA LinkGeneric
05/2024
1Indicators and Reagents (Reagents)IBA
02/2021
1PercollIBA
12/2020
1streptolysin OIBA
12/2020
1artemisinin (artemisinine)IBA
12/2020
1GasesIBA
12/2019
1HDL CholesterolIBA
01/2019
1Triglycerides (Triacylglycerol)IBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1Antitubercular AgentsIBA
01/2015
1posaconazoleFDA Link
06/2014
1Toll-Like Receptor 4IBA
01/2014
1Complement System Proteins (Complement)IBA
01/2014
1Macrophage Migration-Inhibitory FactorsIBA
08/2013
1insulin receptor-related receptor (IRR)IBA
05/2013
1AcidsIBA
05/2013
1Hypoglycemic Agents (Hypoglycemics)IBA
10/2011
1ArtemisininsIBA
05/2009
1Lumefantrine Drug Combination Artemether (Coartem)FDA Link
05/2009
1Small Interfering RNA (siRNA)IBA
11/2008
1Eukaryotic Translation Initiation Factor 5AIBA
11/2008
1Liposomes (Liposome)IBA
11/2008
1Purinergic P1 Receptors (Adenosine Receptor)IBA
10/2008
1ATL 313IBA
10/2008

Therapy/Procedure

7Therapeutics
01/2023 - 11/2008
4Resuscitation
12/2017 - 07/2012
2Drug Therapy (Chemotherapy)
11/2023 - 12/2020
2Debridement
12/2021 - 12/2015
2Knee Replacement Arthroplasty (Total Knee Replacement)
10/2017 - 12/2015
1Duration of Therapy
10/2017
1Intranasal Administration
11/2008